Interactions between different cell types are essential for multiple biological processes, including immunity, embryonic development and neuronal signalling. Although the dynamics of cell-cell interactions can be monitored in vivo by intravital microscopy 1 , this approach does not provide any information on the receptors and ligands involved or enable the isolation of interacting cells for downstream analysis. Here we describe a complementary approach that uses bacterial sortase A-mediated cell labelling across synapses of immune cells to identify receptor-ligand interactions between cells in living mice, by generating a signal that can subsequently be detected ex vivo by flow cytometry. We call this approach for the labelling of 'kiss-and-run' interactions between immune cells 'Labelling Immune Partnerships by SorTagging Intercellular Contacts' (LIPSTIC). Using LIPSTIC, we show that interactions between dendritic cells and CD4 + T cells during T-cell priming in vivo occur in two distinct modalities: an early, cognate stage, during which CD40-CD40L interactions occur specifically between T cells and antigen-loaded dendritic cells; and a later, non-cognate stage during which these interactions no longer require prior engagement of the T-cell receptor. Therefore, LIPSTIC enables the direct measurement of dynamic cell-cell interactions both in vitro and in vivo. Given its flexibility for use with different receptor-ligand pairs and a range of detectable labels, we expect that this approach will be of use to any field of biology requiring quantification of intercellular communication.
. This affinity is orders of magnitude lower than most receptor-ligand interactions involved in immune function [4] [5] [6] [7] .
To test this system, we transfected two populations of HEK293T cells separately with either G5-CD40 or CD40L-SrtA, mixed the two populations in the presence of the biotinylated SrtA substrate (biotin-LPETG) for 30 min, and then analysed the cells by flow cytometry and western blot. To determine specificity, G5-CD40 cells were also incubated with HEK293T cells transfected with SrtA fused to a CD40L variant carrying two point mutations that strongly impair binding to CD40 8, 9 (CD40L* -SrtA, Extended Data Fig. 2 ) or with untargeted SrtA anchored to the cell surface by the transmembrane domain of PDGFR (SrtA-PDGFR) (Fig. 1b, c) . Flow cytometric analysis showed that G5-CD40 + cells were biotinylated efficiently only when incubated with cells expressing wild-type CD40L-SrtA (Fig. 1d) . Western blotting confirmed that LIPSTIC labelling occurred via co valent modification of G5-CD40 (Fig. 1e ). Specific intercellular labelling was also achieved with other ligand-receptor pairs that are involved in immune cell interactions and neuronal signalling, indicating that LIPSTIC can be used to analyse a variety of molecular interactions ( Fig. 1f- 
h). To visualize the dynamics of LIPSTIC labelling in vitro, we imaged interactions between B cells transduced with G5-CD40 and CD4
+ T cells transduced with CD40L-SrtA and preloaded with Alexa Fluor 647-LPETG. Substrate transfer between T and B cells was observed within minutes of interaction and at the interacting surface (Extended Data Fig. 3 and Supplementary Video 1). We conclude that LIPSTIC is an efficient, specific and versatile method that is able to label receptor-ligand interactions across cells in vitro, suitable for use with multiple receptor-ligand pairs and for detection by both flow cyto metry and microscopy.
To determine whether LIPSTIC can function in vivo and at endogenous levels of receptor and ligand expression, we generated mice carrying Cd40 G5 and Cd40lg SrtA alleles targeted to their endogenous loci (Extended Data Fig. 4 ). Expression of G5-CD40 was made constitutive, whereas expression of CD40L-SrtA was designed to occur only after Cre-mediated excision of a translational stop cassette, in order to specify the SrtA + donor cell population. To measure LIPSTIC labelling during antigen-specific interactions between T cells and antigen-presenting cells, we crossed Cd40lg
SrtA to CD4-Cre and to OT-II TCR mice, which express a T-cell receptor specific for the chicken ovalbumin (OVA) peptide OVA 323-339 (we refer to this strain as OT-IISrtA). We co-cultured OT-II-SrtA CD4
+ T cells for 6 h with Cd40
G5/G5
splenic dendritic cells treated either with OVA 323-339 or with a control LCMV-GP 61-80 peptide and added the biotinylated substrate during the final 20 min of culture (Fig. 2a ). Efficient intercellular labelling only occurred when dendritic cells were treated with the cognate peptide, which correlated with induction of CD40L-SrtA expression on T cells. Dendritic cell labelling was strongly inhibited by addition of a CD40L-blocking antibody, confirming that the CD40-CD40L interaction is required (Fig. 2b, c) . LIPSTIC labelling was dose-responsive over a six-log range of OVA peptide concentrations (Fig. 2d, e) . Co-culture of OT-II-SrtA CD4 + T cells with two Cd40 G5/G5 dendritic cell populations separately pulsed with either the OVA 323-339 or control LCMV-GP [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] peptide showed that labelling was restricted to dendritic cells loaded with the cognate antigen, also across a wide range of antigen doses ( Fig. 2f-h ). Whereas labelling of cognate dendritic cells increased Letter reSeArCH when the substrate was incubated for a longer time, labelling of control dendritic cells was negligible even when the substrate was present for the full 6 h of co-culture (Extended Data Fig. 5a-c) . LIPSTIC was also capable of specifically identifying B cells that were productively engaged with antigen, as determined by co-culture of antigen-specific and polyclonal B cells with OT-II-SrtA CD4 + T cells (Extended Data Fig. 5d-g ). Therefore, LIPSTIC labelling in short-term ex vivo priming experiments is dependent on interactions between receptor and ligand, dose-responsive across a wide range of antigen concentrations, and specific to target cells displaying cognate antigens. Of note, although SrtA-CD40L was capable of stimulating B-cell activation when expressed on HEK293T cells (Extended Data Fig. 2c ), B-cell activation by CD40L-SrtA CD4 + T cells was impaired both ex vivo and in vivo when compared to activation by T cells expressing wild-type CD40L, indicating that signalling by CD40L is partly compromised (Extended Data Fig. 6a, b) . This impairment was also seen in mice not carrying the CD4-Cre transgene, which expressed a construct that only had a translated LoxP site added to the C terminus of CD40L (Extended Data  Fig. 6b) ; this impairment therefore more likely represents a specific feature of the CD40L molecule than a general property of SrtA-fusion proteins. Nevertheless, experiments using dendritic cells as antigen-presenting cells showed no measurable effect of the Cd40lg SrtA allele on T-cell proliferation, indicating that the overall kinetics of T-cell priming are not affected by CD40L insufficiency (Extended Data  Fig. 6c) ; we therefore used interactions between T cells and dendritic cells to characterize LIPSTIC labelling in vivo.
To determine whether LIPSTIC can be used in vivo, we used a wellestablished T-cell priming model in which OVA 323-339 -treated Cd40 G5/G5 dendritic cells were injected subcutaneously into the footpad of recipient mice, followed 18 h later by intravenous transfer of OT-II-SrtA CD4 + T cells 10 . We delivered the LIPSTIC substrate to the popliteal lymph node (PLN) by footpad injection of a total of 300 nmol of biotin-LPETG over six injections between 10 and 12 h after T-cell transfer (Fig. 3a) ; T cells are engaged in long-lived interactions with antigen-bearing dendritic cells at this time, as determined by intravital imaging 10 . Flow cyto metry of PLN cells showed efficient LIPSTIC labelling of transferred dendritic cells, which was dependent on T-cell expression of CD40L-SrtA and sensitive to treatment with a CD40L-blocking antibody (Fig. 3b, c and Extended Data Fig. 7a ). Background labelling was negligible in all assayed cell populations (Extended Data Fig. 7b ). To further confirm the dependence of LIPSTIC labelling on CD40-CD40L interaction, we took advantage of the observation that, in the absence of a Cd40 G5 allele, endogenous N-terminal glycines on the cell surface can function as low-efficiency acceptors for the SrtA substrate 11 (Extended Data Fig. 7c, d ). Such labelling was completely absent when Ag-loaded dendritic cells were deficient in Cd40, again showing that CD40-CD40L engagement is essential for labelling (Extended Data Fig. 7e, f) . Analysis of the kinetics of substrate clearance from labelled cells showed that a fraction of the label was still detectable at 4 and 8 h after substrate injection (Extended Data Fig. 7g-k) .
To measure the interaction between CD4 + T cells and endogenous dendritic cells after immunization, we adoptively transferred 
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OT-II-SrtA CD4 + T cells into Cd40 G5/G5 hosts and performed in vivo LIPSTIC labelling at different times after footpad injection of 10 μ g of OVA in an alum adjuvant (Fig. 3d) . LIPSTIC labelling was observed as early as 24 h after immunization on a small fraction of MHC-II hi dendritic cells, which are likely to be pioneer antigen-presenting cells that drive the initiation of the T cell response in the draining lymph node. The fraction of labelled dendritic cells increased over time, peaking at 10-15% of all dendritic cells at 72 h after immunization (Fig. 3e-f 
at low levels-only at 72 h after immunization, in line with previous reports that used intravital imaging and histocytometry 12 ( Fig. 3g, h ). We conclude that LIPSTIC can be used to follow the dynamics of CD40-CD40L contacts between T cells and dendritic cells in vivo, with a sufficient signal-to-noise ratio to detect rare and low-intensity interactions.
The finding that the CD40-CD40L interaction between T cells and dendritic cells peaks at 72 h after immunization (Fig. 3f) , in addition to previous studies that have suggested that CD40L may, under certain circumstances, engage its receptor in the absence of antigen presentation [13] [14] [15] , led us to hypothesize that LIPSTIC labelling later in the response may reflect non-cognate interactions between T cells and dendritic cells taking place during the motile 'phase 3' of T-cell priming 10 . To test this hypothesis, we co-transferred into Cd40 G5/G5 hosts two populations of dendritic cells treated independently with either OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] (the cognate population) or LCMV-GP 61-80 (the bystander population), followed by OT-II-SrtA CD4 + T cells (Fig. 4a ). Whereas LIPSTIC labelling at 12 h after T-cell transfer was detected only on cognate dendritic cells, specificity was lost at 48 h, when both transferred and endogenous bystander dendritic cells were robustly labelled (Fig. 4b, c and Extended Data Fig. 8a ). To verify that bystander labelling was truly non-cognate-as opposed to resulting from transfer of antigenic peptide between dendritic cell populations-we performed identical co-transfer experiments, but using H2 −/− dendritic cells as bystanders. LIPSTIC labelling of H2 −/− dendritic cells at late time points was indistinguishable from that of MHC-II-sufficient bystanders under the same conditions (Fig. 4d) . Non-cognate LIPSTIC labelling of bystander dendritic cells at later time points was also observed after OVA immunization of haematopoietic chimaeras reconstituted with 80% Cd40 G5/G5 and 20% Cd40 G5/G5 ;H2 −/− bone marrow (Extended Data Fig. 8c -e), and during ex vivo priming experiments analogous to those described in Fig. 2 (Extended Data Fig. 9 ). Thus, CD40L-CD40 LIPSTIC labelling during late stages of T-cell priming is not restricted to dendritic cells presenting the cognate antigen, in three distinct priming models.
To confirm non-cognate CD40-CD40L interactions in a system independent of LIPSTIC, we took advantage of the observation that CD40-dependent downregulation of surface CD40L on T cells can be used as a surrogate reporter for the CD40-CD40L interaction in vivo 14 . We injected wild-type OVA Letter reSeArCH T-cell transfer. Whereas downregulation of CD40L could be observed in T cells transferred into wild-type hosts, this was not the case for T cells transferred into Cd40 −/− hosts, despite the presence of CD40 on the transferred Ag-loaded dendritic cells. CD40L downregulation was comparable in wild-type and in B-cell-deficient (J H T) hosts, indicating that B cells do not contribute to CD40L downregulation (Fig. 4e, f) . Thus, CD40L-CD40 interactions between T cells and with non-B cell antigen-presenting cells that are not loaded with antigen can downregu late surface CD40L on the T cell, confirming the interactions between activated T cells and bystander dendritic cells revealed by LIPTSIC. Moreover, similar downregulation of CD40L was observed in OT-II-SrtA T cells, indicating that the SrtA fusion does not prevent the downregulation of CD40L after it engages CD40 (Fig. 4e-f) .
Gene expression profiling of bystander biotin + and biotin − host dendritic cells revealed clear differences between these two populations. Principal component analysis detected a major component (accounting for 51% of total variance) for which biotin + dendritic cells were clearly separated from biotin − dendritic cells, which in turn resembled bystander dendritic cells from mice lacking CD40 (Fig. 4g) , a conclusion also supported by hierarchical clustering (Extended Data Fig. 10c ). Differential expression analysis identified 788 genes that differed significantly between conditions (fold change > 2 and false-discovery rate < 0.05) (listed in Extended Data Fig. 10d and Supplementary Table1). We conclude that bystander interactions between T cells and dendritic cells are associated with marked changes in gene expression, and CD40 ligation potentially has a role in these alterations.
Finally, to determine whether the change in the pattern of interaction between T cells and dendritic cells over time is due to a change in the properties of T cells or of dendritic cells, we repeated the OVA 323-339 /LCMV-GP 61-80 dendritic cell co-transfer experiment but this time delaying T-cell transfer to 62 h after dendritic cell injection, so that, at the time of labelling, dendritic cells had been in the host for 70 h but T cells for only 12 h (Fig. 4h) . This rescued the specificity of T-cell interactions, in that only dendritic cells treated with OVA 323-339 peptide were labelled (Fig. 4i) . Thus, newly primed T cells retain their specificity even when antigen-bearing dendritic cells have been present for several days. We conclude that CD40-CD40L interactions between CD4 + T cells and dendritic cells proceed in two stages. Initially, CD40L signals from arrested T cells are delivered specifically to antigen-loaded dendritic cells that are priming the response. This is followed by an antigen-independent stage in which motile, activated T cells are capable of interacting via CD40L even with dendritic cells that are not presenting the cognate antigen.
We introduce LIPSTIC, a novel system for labelling cell-cell interactions enzymatically both in vitro and in vivo. Although similar approaches have been proposed previously [16] [17] [18] , our system has a number of unique features: first, the use of a mutated version of SrtA with low affinity for the N-terminal oligoglycine makes SrtA less likely to be the driver of the cell-cell interaction and more likely to operate as a readout of interactions driven by high-affinity receptor-ligand pairs. Second, SrtA uses a peptide substrate that is easily synthesized and can be linked to a wide variety of detectable labels, including genetically encoded fluorescent proteins or epitope tags 2 . Third, and most importantly, SrtA substrates can be readily administered to live animals, allowing us to detect and isolate cells based on their history of intercellular interactions in vivo. Given the importance of such interactions to immunology and other fields of biomedical science, we expect this technology will be widely useful to biologists in general, representing a useful complement to intravital microscopy.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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Data reporting.
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Plasmids. All constructs were cloned into the pMP71 vector 19 , which was modified to express a fluorescent reporter (eGFP or Tomato) followed by the porcine teschovirus-1 self-cleavable 2A peptide 20 and the protein of interest. The SrtA sequence, including a terminal Flag-tag, was attached by a double 218 linker 21 to the extracellular terminus of the modified receptor or ligand (C or N terminus, depending on protein topology). A five-glycine tag (G5) followed by a Myc tag was fused at the N terminus of modified receptors or ligands. The sequences of all constructs used are included in Supplementary 29 
Generation of Cd40
G5 and Cd40lg SrtA mice. The Cd40 G5 mouse line was generated using CRISPR-Cas9 gene targeting by cytoplasmic injection of Cas9 mRNA, chimeric single-guide RNA (sgRNA) and a repair oligonucleotide into fertilized C57BL/6 zygotes at the one-cell stage, as previously described 30, 31 . The sequence for the dsDNA template for chimeric Cd40 G5 sgRNA transcription was as follows (protospacer sequence is u nd er li ned): C GC TG TT AA TA CG AC TC A  C TA TA GG TC TG TT TT TA GG TC CA TC TA GT TT TA GA GC TA GA AA TA GC AA  GT TA AA AT AA GG CT AG TCCGTTATCAACTTGAAAAAGTGGCACCGAGTC  GGTGCTTTT. The Cd40 G5 repair oligonucleotide was synthesized as an ssDNA ultramer and PAGE-purified (Integrated DNA Technologies). The repair oligonucleotide sequence was as follows (differences from the wild-type C57BL/6 sequence are underlined): T GG CT GG CA CA AA TC AC AG CA CT GG CC AT CG TG GA GG TA CT GT TT GT CA CT GC AC GT AA C GG TA CC TC CT CC GC CT CC A CA CT GC CC TA GA TG TACCTAAAAACAGAAGTGGACAGCTGGAAGGGATCTTCCA CCGGC.
The Cd40lg SrtA mouse line was generated using CRISPR-Cas9 gene targeting by cytoplasmic injection of Cas9 mRNA, chimeric sgRNA, SCR7 (an NHEJ inhibitor, Excess Bioscience) and the repair plasmid into fertilized C57BL/6 zygotes at the one-cell stage, as described in ref. 32 , with the exception that the final concentration of SCR7 used was 100 μ M.
The sequence of the dsDNA template for chimeric Cd40lg SrtA sgRNA transcription was as follows (protospacer sequence is u nd er li ned): C GC TG TT AA TA CG AC TC AC TA TA GG A GA GT TG GC TT CT CA TC TT T GT TT TA GA GC TA GA AA TA GC AA GT TA AA AT AA GG CT AG TCCGTTATCAACTTGAAAAAGTGG CACCGAGTCGGTGCTTTT.
The sequence of the Cd40lg SrtA targeting construct is reported in Supplementary  Table 2 .
Cas9 mRNA was purchased from Sigma-Aldrich. Chimeric sgRNAs were in vitro-transcribed from a synthetic dsDNA template (gBlocks, Integrated DNA Technologies) using the MEGAshortscript T7 Transcription Kit (Thermo Fisher Scientific) and purified using Ampure XP beads (Beckman Coulter).
Isolation of splenic dendritic cells, CD4
+ T cells and B cells. To isolate dendritic cells, spleens were collected, incubated for 30 min at 37 °C in RPMI, 2% FBS, 20 mM HEPES, 400 U ml −1 type-IV collagenase (Worthington Biochemical) and disrupted to generate single-cell suspensions. Red-blood cells were lysed with ACK buffer (Lonza), and the resulting cell suspensions were filtered through a 70-μ m mesh into PBS supplemented with 0.5% BSA and 2 mM EDTA (PBE). Dendritic cells were obtained by magnetic cell separation (MACS) using antiCD11c beads (Miltenyi Biotec), as per the manufacturer's instructions. To isolate CD4 + T cells and B cells, spleens were processed as above, except for collagenase digestion, which was not performed. CD4
+ T cells were isolated using the CD4 + T cell isolation kit (Miltenyi Biotec), whereas B cells were obtained by negative selection using anti-CD43 beads (Miltenyi Biotec), as per the manufacturer's instructions. To isolate Igλ + B cells from B1-8 hi mice, B cells were stained with anti-Igκ -PE antibody and subsequently purified by negative selection using a combination of anti-CD43 and anti-PE magnetic beads (Miltenyi Biotec).
Cell transfers, immunizations and treatments. For dendritic cell transfer experiments, splenic dendritic cells isolated as described above were resuspended at 10 7 cells per ml and treated with 10 μ M OVA 323-339 or LCMV-GP 61-80 (both from Anaspec) in RPMI, 10% FBS, for 30 min at 37 °C. For cell labelling, CFSE was added to a final concentration of 2 μ M during the last 5 min of incubation. Cells were then washed three times in RPMI, 10% FBS and resuspended at 2 × 10 7 cells per ml in PBS supplemented with 0.4 μ g ml −1 LPS. Dendritic cells were injected (5 × 10 5 cells in 25 μ l) by subcutaneous injection into the hind footpad. For CD4 + T-cell transfer experiments, CD4
+ T cells isolated as described above were resuspended at 3 × 10 6 cells per ml in PBS and injected intravenously (3 × 10 5 cells in 100 μ l per mouse). For immunization experiments, mice were immunized by subcutaneous injection into the hind footpad with 10 μ g OVA adsorbed in alum (Imject Alum, Thermo Fisher Scientific) at 2:1 antigen:alum (v:v) ratio in 25 μ l volume.
For LIPSTIC in vivo labelling experiments, biotin-LPETG (see below) was injected subcutaneously into the hind footpad (20 μ l of 2.5 mM solution in PBS, equivalent to 50 nmol). Mice were injected six times 20 min apart, and popliteal lymph nodes were collected 40 min after the last injection. Mice were briefly anaesthetized with isoflurane at each injection. type-IV collagenase (Worthington Biochemical), disrupted using disposable micropestles (Axygen) and filtered through a 70-μ m cell strainer. Single-cell suspensions were washed with PBE, incubated at room temperature for 5 min with 1 μ g ml −1 of anti-CD16/32 (2.4G2, BioXCell) and then stained for cell surface markers at 4 °C for 15 min in PBE using the reagents listed in Supplementary  Table 3 . Cells were washed with PBS and stained with Zombie fixable viability dyes (Biolegend) at room temperature for 15 min and then fixed with Cytofix (BD Biosciences) before acquisition. In all in vivo experiments involving detection of biotin-LPETG SrtA substrate, an anti-biotin-PE antibody (Miltenyi Biotec) was exclusively used owing to its lower background compared to streptavidin conjugates. To eliminate unspecific signals derived from PE binding by a fraction of the B-cell population and thus reduce background, PE-Cy7 isotype controlpositive cells were excluded from analysis. In all in vivo experiments involving detection of CD40L, a biotinylated anti-CD40L antibody (eBioscience) followed by an anti-biotin PE antibody (Miltenyi Biotec) was used. Samples were acquired on Fortessa or LSR-II flow cytometers (BD Biosciences) and data were analysed using FlowJo v. 10 
XCR1
− dendritic cells were also sorted from Cd40 −/− mice treated as above, except that they received wild-type (instead of Cd40
G5/G5
) dendritic cells and wild-type OT-II (instead of CD40lg
SrtA/Y CD4-Cre OT-II) CD4 + T cells. Fresh cells were sorted (150 cells per sample) directly into plates containing TCL buffer (Qiagen) supplemented with 1% b -mercaptoethanol using a FACS Aria II (BD Biosciences). RNA from sorted populations was isolated using Agencourt RNAClean XP beads (Beckman Coulter). Full-length cDNA and sequencing libraries were prepared using the Smart-seq2 protocol as previously described 33 . Libraries were sequenced on a Nextseq500 (Illumina) to generate 38-base-pair, paired-end reads.
Raw sequencing data were processed as described 34 . In brief, short sequencing reads were aligned to the UCSC mm10 transcriptome using Bowtie2 (v.2.1.0) 35 . These alignments were used as input in RSEM (v.1.2.8) 36 to quantify gene expression levels for all UCSC mm10 genes in all samples. Data were normalized and analysed using the R software package DESeq2 (v.1.16.0) 37 . Genes with low read counts, defined as those that do not have a normalized expression value greater than 100 in at least three samples, were filtered out, leaving 10,196 genes for the downstream analysis. The 500 genes with the largest variance were used for the principal component analysis and hierarchical clustering. For hierarchical clustering, the complete linkage clustering method was applied on pairwise Letter reSeArCH distances, defined as 1 minus the Pearson correlation coefficient. Paired differential expression analysis was performed for comparison between biotin + and biotin − dendritic cell samples. The differentially expressed genes were compared against the MSigDB database to compute for enrichment using the hyper geometric test 38 . Bone marrow chimaeras. C57BL6/J recipient mice were lethally irradiated with two doses of 450 Rads given 4 h apart. After irradiation, recipients were reconstituted by intravenous injection of haematopoietic cells collected from femurs and tibiae of donor mice. Mice were used for experiments 8-12 weeks after irradiation. Western blot. Cells were lysed in sample buffer supplemented with 100 mM dithiothreitol. Cell lysates were heated at 98 °C for 5 min and then cleared by centrifugation at 15,000g for 10 min. Samples were separated by SDS-PAGE and transferred onto a nitrocellulose membrane. After blocking in 3% skim milk in PBS, membranes were incubated with 1-10 μ g ml −1 primary antibody in 3% skim milk in PBS overnight at 4 °C. After several washes in PBS and 0.1% Tween-20 (PBST), secondary antibodies coupled to HRP were applied in PBST for 1 h at room temperature when necessary. Blots were developed using Western Lightning ECL (Perkin-Elmer) and BioMax MR films (Kodak). SrtA substrates. Biotin-aminohexanoic acid-LPETGS (C-terminal amide, 95% purity) was purchased from LifeTein (custom synthesis) and stock solutions prepared in PBS at 20 mM.
SELPETGG (C-terminal amide, 95% purity) was purchased from LifeTein (custom synthesis) and conjugated with AlexaFluor647 succinimidyl ester dye (Thermo Fisher Scientific). Reacted peptides were purified by HPLC. Southern blot. Genomic DNA (10 μ g) purified from mouse tails was digested with XbaI and separated on 0.8% agarose gel. Transfer and hybridization was performed as described 39 . Blots were developed using Storage Phosphor Screens (GE Healthcare) and a Typhoon Imaging System (GE Healthcare). The sequence of the probe used was as f ol lo ws: G GT CA AC CT GG GT TC CA TA AA AT CTTG TC TT CC CC CA AA AG GG GA TA AA TT CA GT AG AC AG AG GC AG GTAGATCT CTGTGAGTCCCAAGCTAGCCTAGTCTGCATAACAAGTTGTAGGCCAGCT TCTGTTTTCTTTTCTGTCTCAAAAAAGAAAGCAGAAGTGTAAGTGGGT AATGTATTTATTAAACTGAAAAGAATCTGGTCCTTTTTTTCTCATTCAA ATGGTTCAAAAGTGAAAACATCACAAAACAAACATCCTTTATAGAGAA TTTGGGGTGCAATGTATCAG. LIPSTIC in vitro. HEK293T cells (purchased from ATCC) were transfected using the calcium phosphate transfection kit (Thermo Fisher Scientific) with the indicated expression vectors. Forty hours after transfection, cells were detached using a non-enzymatic cell dissociation solution (Thermo Fisher Scientific), washed and resuspended at 10 7 cell per ml in PBS. Cell populations transfected with G5-or SrtA-fusion constructs were mixed at a 1:1 ratio (10 6 cells of each population) in a 1.5-ml conical tube, to which biotin-LPETG was added to a final concentration of 100 μ M. Cells were incubated at room temperature for 30 min and washed three times with PBE to remove excess biotin-LPETG before FACS staining or western blot.
Imaging LIPSTIC in vitro. B cells and CD4
+ T cells were isolated from mouse spleens as described above; B cells were activated with 25 μ g ml −1 LPS and 10 ng ml −1 IL-4, whereas CD4 + T cells were activated with CD3/CD28 dynabeads and rat T-STIM conditioned medium (both from Thermo Fisher Scientific). Twenty-four hours later, cells were transduced with retroviral vectors. Transduced cells were sorted two days after transduction based on expression of the fluorescent reporter present in the retroviral vector. CD4 + T cells were incubated with AlexaFluor647-SELPETGG for 30 min at 37 °C, washed three times, and seeded together with B cells on 8-well Lab-Tek chamber slides (Sigma-Aldrich) previously coated with 12.5 μ g ml −1 ICAM (2 × 10 5 cells per well, 1:1 ratio). Cells were immediately imaged using an Andor widefield microscope equipped with a live-cell incubation system. Images were acquired with a 40× objective every 45 s for 90 min using Metamorph software.
LIPSTIC ex vivo. Dendritic cells, B cells and CD4
+ T cells were isolated from mouse spleens as described above.
Isolated dendritic cells were treated for 2.5 h at 37 °C with the indicated concentration of OVA 323-339 or LCMV-GP 61-80 peptides in RPMI, 10% FBS supplemented with LPS (10 μ g ml
), washed three times and then seeded into U-bottom 96-well plates with purified CD4 + T cells (2 × 10 5 cells per well, 1:1 ratio). Cells were co-cultured for 6 ( Fig. 2 and Extended Data Fig. 5 ) or 24 h (Extended Data   Fig. 9) , and biotin-LPETG was added at the indicated time of co-culture at a final concentration of 10 μ M in complete medium. Blocking antibodies were added at the beginning of co-culture (Fig. 2) or at the indicated times (Extended Data Fig. 9 ) and used at a final concentration of 150 μ g ml −1
.
Purified B cells (either polyclonal or Igλ
+ B1-8 hi ) were cooled for 30 min on ice and then incubated for 45 min on ice with the indicated concentrations of NP-OVA (Biosearch Technologies). Cells were then washed twice and seeded into U-bottom 96-well plates with CD4 + T cells (2 × 10 5 cells per well, 1:1 ratio) previously activated with CD3/CD28 dynabeads (Thermo Fisher Scientific) for 24 h. Cells were co-cultured for 18 h and biotin− LPETG was added during the last 30 min of co-culture at a final concentration of 100 μ M in complete medium.
For all experiments, cells were washed three times with PBE before FACS staining to remove excess biotin-LPETG substrate. Statistical analysis. Statistical tests were conducted using Prism (GraphPad) software. Gaussian distribution was confirmed by the Shapiro-Wilk normality test. Unpaired, two-tailed Student's t-tests and one-way ANOVA with Tukey's post hoc tests to further examine pairwise differences were used. Data availability. RNA-sequencing data are deposited in GEO under accession number GSE107643. All other data are included within the article and the Supplementary Information or are available upon request from the corresponding author.
Letter reSeArCH
Extended Data Figure 2 | Two point mutations in the mouse CD40L coding sequence impair binding to CD40. a, Sequence alignment of human and mouse CD40L proteins. Owing to the lack of crystallographic data describing the mouse CD40-CD40L complex, we identified residues potentially engaged in CD40 binding on the basis of information available for the human CD40-CD40L complex. Residues in human CD40L sequences engaged in the interaction with CD40 based on crystallographic data are highlighted in blue. Among these, residues for which a charge reversal mutation was shown to affect CD40 binding are boxed. Filled boxes identify the residues in mouse CD40L for which a charge reversal mutation was performed (K142E and R202E). Mutations at equivalent locations in the human CD40L coding sequence (K143, R203) have also SrtA/Y CD4-Cre OT-II CD4 + T cells in vivo after dendritic cell transfer. Mice were treated as in Fig. 3a Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined.
We did not predetermine sample size. All experiments were performed multiple times and conclusions were considered valid if results were reproducible between experiments.
Data exclusions
Describe any data exclusions. For FACS analysis of DCs in lymph nodes, low count samples (< 300'000 total events) where excluded due to the inability to clearly identify rare DC populations.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were not randomized. Donor mice were chosen based on their genotype. Recipient mice were allocated so that experimental and control groups were housed within the same cage.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were not blinded to group allocation during experiments and outcome assessment.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
